12:46 PM EDT, 05/24/2024 (MT Newswires) -- Cyclo Therapeutics ( CYTH ) filed a registration statement covering the potential sale of up to $100 million worth of its securities.

The prospectus covers the sale from time to time of common stock, preferred stock, warrants, units or any combination of the securities, the company said Friday in a regulatory filing.

Net proceeds from the potential sale will be used for general corporate purposes, and a portion might be for research and development of product candidates, the company said.

Shares of Cyclo Therapeutics ( CYTH ) rose 7% in recent trading Friday.

Price: 1.39, Change: +0.09, Percent Change: +7.00